Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Positief advies vergoeding etranacogene dezaparvovec (Hemgenix) voor behandeling hemofilie B
jul 2024 | Benigne hematologie